Literature DB >> 15802307

NK cell activation and protection occur independently of natural killer T cells during Trypanosoma cruzi infection.

Malcolm S Duthie1, Stuart J Kahn.   

Abstract

Natural killer T (NKT) cells regulate aspects of pro-inflammatory and anti-inflammatory responses and contribute to the control of infections and chronic inflammatory diseases. During Trypanosoma cruzi infection both NKT cells and NK cells are critical to the protective response. How NKT cells interact and possibly regulate NK cells during infections remains uncertain. In vivo studies have demonstrated that specific activation of NKT cells with alpha-galactosylceramide (alpha-GalCer) leads to NK cell activation. These results suggest that during some infections activated NKT cells might regulate NK cell activation and functions. Therefore, using gene-deficient mice that lack NKT cells and antibody-treated mice that lack NK cells, we investigated the interactions of NKT cells and NK cells during experimental T. cruzi infection. We report here that during acute T. cruzi infection spleen and liver NK cell activation and cytolytic activity occur independently of NKT cells. Moreover, NK cell protection occurs independently of NKT cells. In contrast to these results that fail to demonstrate an interdependence, at day 4 of infection the number of liver NK cells is controlled by NKT cells. Thus, during T. cruzi infection, regulation of the number of liver NK cells requires NKT cells, but the activation of NK cells and protection by NK cells does not. The data presented here argue that during infections NK cell activation and protection occur independently of NKT cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15802307     DOI: 10.1093/intimm/dxh239

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  8 in total

Review 1.  Evolutionary struggles between NK cells and viruses.

Authors:  Lewis L Lanier
Journal:  Nat Rev Immunol       Date:  2008-03-14       Impact factor: 53.106

2.  During acute Trypanosoma cruzi infection highly susceptible mice deficient in natural killer cells are protected by a single alpha-galactosylceramide treatment.

Authors:  Malcolm S Duthie; Stuart J Kahn
Journal:  Immunology       Date:  2006-07-26       Impact factor: 7.397

3.  MicroRNA-155 Deficiency Exacerbates Trypanosoma cruzi Infection.

Authors:  Bijay K Jha; Sanjay Varikuti; Abhay R Satoskar; Bradford S McGwire; Gabriella R Seidler; Greta Volpedo
Journal:  Infect Immun       Date:  2020-06-22       Impact factor: 3.441

4.  Differential modulating effect of natural killer (NK) T cells on interferon-γ production and cytotoxic function of NK cells and its relationship with NK subsets in Chlamydia muridarum infection.

Authors:  Lei Zhao; Xiaoling Gao; Ying Peng; Antony G Joyee; Hong Bai; Shuhe Wang; Jie Yang; Weiming Zhao; Xi Yang
Journal:  Immunology       Date:  2011-10       Impact factor: 7.397

5.  Direct CD1d-mediated stimulation of APC IL-12 production and protective immune response to virus infection in vivo.

Authors:  Simon C Yue; Michael Nowak; Angela Shaulov-Kask; RuoJie Wang; Dominic Yue; Steven P Balk; Mark A Exley
Journal:  J Immunol       Date:  2009-11-30       Impact factor: 5.422

6.  Induction of Effective Immunity against Trypanosoma cruzi.

Authors:  Tere Williams; Ignacio Guerrero-Ros; Yanfen Ma; Fabiane Matos Dos Santos; Philipp E Scherer; Ruth Gordillo; Aline Horta; Fernando Macian; Louis M Weiss; Huan Huang
Journal:  Infect Immun       Date:  2020-03-23       Impact factor: 3.441

7.  The Ly49E Receptor Inhibits the Immune Control of Acute Trypanosoma cruzi Infection.

Authors:  Jessica Filtjens; Nicolas Coltel; Sabrina Cencig; Sylvie Taveirne; Els Van Ammel; Aline Van Acker; Tessa Kerre; Patrick Matthys; Tom Taghon; Bart Vandekerckhove; Yves Carlier; Carine Truyens; Georges Leclercq
Journal:  Front Immunol       Date:  2016-11-10       Impact factor: 7.561

Review 8.  Natural killer cells as an initial defense against pathogens.

Authors:  Melissa B Lodoen; Lewis L Lanier
Journal:  Curr Opin Immunol       Date:  2006-06-12       Impact factor: 7.486

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.